Developmental milestones and daily living skills in individuals with Angelman syndrome.


Journal

Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832

Informations de publication

Date de publication:
15 Jun 2024
Historique:
received: 16 08 2023
accepted: 29 05 2024
medline: 16 6 2024
pubmed: 16 6 2024
entrez: 15 6 2024
Statut: epublish

Résumé

Angelman syndrome (AS) is a neurodevelopmental disorder associated with severe global developmental delay. However, the ages at which different developmental skills are achieved in these individuals remain unclear. We seek to determine the probability and the age of acquisition of specific developmental milestones and daily living skills in individuals with AS across the different molecular subtypes, viz. class I deletion, class II deletion, uniparental disomy, imprinting defect, and UBE3A variants. Caregivers participating in a longitudinal multicenter Angelman Syndrome Natural History Study completed a questionnaire regarding the age at which their children achieved specific developmental milestones and daily living skills. The Cox Proportional Hazard model was applied to analyze differences in the probability of achievement of skills at various ages among five molecular subtypes of AS. Almost all individuals, regardless of molecular subtype, were able to walk with support by five years of age. By age 15, those with a deletion had at least a 50% probability of acquiring 17 out of 30 skills compared to 25 out of 30 skills among those without a deletion. Overall, fine and gross motor skills such as holding and reaching for small objects, sitting, and walking with support were achieved within a fairly narrow range of ages, while toileting, feeding, and hygiene skills tend to have greater variability in the ages at which these skills were achieved. Those without a deletion had a higher probability (25-92%) of achieving daily living skills such as independently toileting and dressing compared to those with a deletion (0-13%). Across all molecular subtypes, there was a low probability of achieving independence in bathing and brushing teeth. Individuals with AS without a deletion are more likely to achieve developmental milestones and daily living skills at an earlier age than those with a deletion. Many individuals with AS are unable to achieve daily living skills necessary for independent self-care.

Sections du résumé

BACKGROUND BACKGROUND
Angelman syndrome (AS) is a neurodevelopmental disorder associated with severe global developmental delay. However, the ages at which different developmental skills are achieved in these individuals remain unclear. We seek to determine the probability and the age of acquisition of specific developmental milestones and daily living skills in individuals with AS across the different molecular subtypes, viz. class I deletion, class II deletion, uniparental disomy, imprinting defect, and UBE3A variants.
METHODS METHODS
Caregivers participating in a longitudinal multicenter Angelman Syndrome Natural History Study completed a questionnaire regarding the age at which their children achieved specific developmental milestones and daily living skills. The Cox Proportional Hazard model was applied to analyze differences in the probability of achievement of skills at various ages among five molecular subtypes of AS.
RESULTS RESULTS
Almost all individuals, regardless of molecular subtype, were able to walk with support by five years of age. By age 15, those with a deletion had at least a 50% probability of acquiring 17 out of 30 skills compared to 25 out of 30 skills among those without a deletion. Overall, fine and gross motor skills such as holding and reaching for small objects, sitting, and walking with support were achieved within a fairly narrow range of ages, while toileting, feeding, and hygiene skills tend to have greater variability in the ages at which these skills were achieved. Those without a deletion had a higher probability (25-92%) of achieving daily living skills such as independently toileting and dressing compared to those with a deletion (0-13%). Across all molecular subtypes, there was a low probability of achieving independence in bathing and brushing teeth.
CONCLUSION CONCLUSIONS
Individuals with AS without a deletion are more likely to achieve developmental milestones and daily living skills at an earlier age than those with a deletion. Many individuals with AS are unable to achieve daily living skills necessary for independent self-care.

Identifiants

pubmed: 38879552
doi: 10.1186/s11689-024-09548-7
pii: 10.1186/s11689-024-09548-7
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Subventions

Organisme : Foundation for the National Institutes of Health
ID : HD061222
Organisme : NCRR NIH HHS
ID : U54 RR019478
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Bird LM. Angelman syndrome: review of clinical and molecular aspects. Appl Clin Genet. 2014;7:93–104.
doi: 10.2147/TACG.S57386 pubmed: 24876791 pmcid: 4036146
Dagli AI, Mathews J, Williams CA. Angelman Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Stephens K,et al. editors. GeneReviews® Seattle (WA): University of Washington, Seattle; 1998 [updated 2021].
Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2006;140(5):413–8.
doi: 10.1002/ajmg.a.31074 pubmed: 16470747
Luk HM, Lo IF. Angelman syndrome in Hong Kong Chinese: A 20 years’ experience. Eur J Med Genet. 2016;59(6–7):315–9.
doi: 10.1016/j.ejmg.2016.05.003 pubmed: 27174604
Mertz LG, Christensen R, Vogel I, Hertz JM, Nielsen KB, Gronskov K, et al. Angelman syndrome in Denmark. birth incidence, genetic findings, and age at diagnosis. Am J Med Genet A. 2013;161A(9):2197–203.
doi: 10.1002/ajmg.a.36058 pubmed: 23913711
Oiglane-Shlik E, Talvik T, Zordania R, Poder H, Kahre T, Raukas E, et al. Prevalence of Angelman syndrome and Prader-Willi syndrome in Estonian children: sister syndromes not equally represented. Am J Med Genet A. 2006;140(18):1936–43.
doi: 10.1002/ajmg.a.31423 pubmed: 16906556
Petersen MB, Brondum-Nielsen K, Hansen LK, Wulff K. Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county. Am J Med Genet. 1995;60(3):261–2.
doi: 10.1002/ajmg.1320600317 pubmed: 7573182
Yakoreva M, Kahre T, Zordania R, Reinson K, Teek R, Tillmann V, et al. A retrospective analysis of the prevalence of imprinting disorders in Estonia from 1998 to 2016. Eur J Hum Genet. 2019;27(11):1649–58.
doi: 10.1038/s41431-019-0446-x pubmed: 31186545 pmcid: 6871525
Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15(1):70–3.
doi: 10.1038/ng0197-70 pubmed: 8988171
Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 1997;15(1):74–7.
doi: 10.1038/ng0197-74 pubmed: 8988172
Dagli A, Buiting K, Williams CA. Molecular and Clinical Aspects of Angelman Syndrome. Mol Syndromol. 2012;2(3–5):100–12.
pubmed: 22670133
Clayton-Smith J, Laan L. Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet. 2003;40(2):87–95.
doi: 10.1136/jmg.40.2.87 pubmed: 12566516 pmcid: 1735357
Buiting K, Williams C, Horsthemke B. Angelman syndrome - insights into a rare neurogenetic disorder. Nat Rev Neurol. 2016;12(10):584–93.
doi: 10.1038/nrneurol.2016.133 pubmed: 27615419
Beygo J, Buiting K, Ramsden SC, Ellis R, Clayton-Smith J, Kanber D. Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes. Eur J Hum Genet. 2019;27(9):1326–40.
doi: 10.1038/s41431-019-0435-0 pubmed: 31235867 pmcid: 6777528
Mertz LG, Thaulov P, Trillingsgaard A, Christensen R, Vogel I, Hertz JM, et al. Neurodevelopmental outcome in Angelman syndrome: genotype-phenotype correlations. Res Dev Disabil. 2014;35(7):1742–7.
doi: 10.1016/j.ridd.2014.02.018 pubmed: 24656292
Bindels-de Heus K, Mous SE, Ten Hooven-Radstaake M, van Iperen-Kolk BM, Navis C, Rietman AB, et al. An overview of health issues and development in a large clinical cohort of children with Angelman syndrome. Am J Med Genet A. 2020;182(1):53–63.
doi: 10.1002/ajmg.a.61382 pubmed: 31729827
Gentile JK, Tan WH, Horowitz LT, Bacino CA, Skinner SA, Barbieri-Welge R, et al. A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations. J Dev Behav Pediatr. 2010;31(7):592–601.
doi: 10.1097/DBP.0b013e3181ee408e pubmed: 20729760 pmcid: 2997715
Peters SU, Goddard-Finegold J, Beaudet AL, Madduri N, Turcich M, Bacino CA. Cognitive and adaptive behavior profiles of children with Angelman syndrome. Am J Med Genet A. 2004;128(2):110–3.
doi: 10.1002/ajmg.a.30065
Sadhwani A, Wheeler A, Gwaltney A, Peters SU, Barbieri-Welge RL, Horowitz LT, et al. Developmental Skills of Individuals with Angelman Syndrome Assessed Using the Bayley-III. J Autism Dev Disord. 2023;53(2):720–37.
Keute M, Miller MT, Krishnan ML, Sadhwani A, Chamberlain S, Thibert RL, et al. Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment. Mol Psychiatry. 2021;26(7):3625–33.
doi: 10.1038/s41380-020-0858-6 pubmed: 32792659
Brun Gasca C, Obiols JE, Bonillo A, Artigas J, Lorente I, Gabau E, Guitart M, Turk J. Adaptive behaviour in Angelman syndrome: its profile and relationship to age. J Intellect Disabil Res. 2010;54(11):1024–9.
doi: 10.1111/j.1365-2788.2010.01331.x pubmed: 20854288
Roche L, Tones M, Cross M, Bellgard M, Heussler H. An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry. Advances in Neurodevelopmental Disorders. 2022;9:1–4.
Gwaltney A, Potter SN, Peters SU, Barbieri-Welge RL, Horowitz LT, Noll LM et al. Adaptive Skills of Individuals with Angelman Syndrome Assessed Using the Vineland Adaptive Behavior Scales, 2nd Edition. J Autism Dev Disord. 2023. https://doi.org/10.1007/s10803-023-06090-8 .
Yang L, Shu X, Mao S, Wang Y, Du X, Zou C. Genotype-Phenotype Correlations in Angelman Syndrome. Genes (Basel). 2021;12(7):987.
doi: 10.3390/genes12070987 pubmed: 34203304 pmcid: 8304328
Wheeler AC, Okoniewski KC, Wylie A, DeRamus M, Hiruma LS, Toth D, et al. Anxiety-associated and separation distress-associated behaviours in Angelman syndrome. J Intellect Disabil Res. 2019;63(10):1234–47.
doi: 10.1111/jir.12635 pubmed: 31134691
Lossie AC, Whitney MM, Amidon D, Dong HJ, Chen P, Theriaque D, et al. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet. 2001;38(12):834–45.
doi: 10.1136/jmg.38.12.834 pubmed: 11748306 pmcid: 1734773
Weston KP, Gao X, Zhao J, Kim KS, Maloney SE, Gotoff J, Parikh S, Leu YC, Wu KP, Shinawi M, Steimel JP, Harrison JS, Yi JJ. Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis. Nat Commun. 2021;12(1):6809.
doi: 10.1038/s41467-021-27156-0 pubmed: 34815418 pmcid: 8635412
Zubler JM, Wiggins LD, Macias MM, Whitaker TM, Shaw JS, Squires JK, Pajek JA, Wolf RB, Slaughter KS, Broughton AS, Gerndt KL, Mlodoch BJ, Lipkin PH. Evidence-Informed Milestones for Developmental Surveillance Tools. Pediatrics. 2022;149(3):e2021052138.
doi: 10.1542/peds.2021-052138 pubmed: 35132439
Joinson C, Heron J, von Gontard A, Butler U, Golding J, Emond A. Early childhood risk factors associated with daytime wetting and soiling in school-age children. J Pediatr Psychol. 2008;33(7):739–50.
doi: 10.1093/jpepsy/jsn008 pubmed: 18263629
Schum TR, Kolb TM, McAuliffe TL, Simms MD, Underhill RL, Lewis M. Sequential acquisition of toilet-training skills: a descriptive study of gender and age differences in normal children. Pediatrics. 2002;109(3):E48. https://doi.org/10.1542/peds.109.3.e48.PMID:11875176.30 .
doi: 10.1542/peds.109.3.e48.PMID:11875176.30 pubmed: 11875176
Grieco JC, Romero B, Flood E, Cabo R, Visootsak J. A Conceptual Model of Angelman Syndrome and Review of Relevant Clinical Outcomes Assessments (COAs). Patient. 2019;12(1):97–112.
doi: 10.1007/s40271-018-0323-7 pubmed: 29987743
Willgoss T, Cassater D, Connor S, Krishnan ML, Miller MT, Dias-Barbosa C, et al. Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model. Child Psychiatry Hum Dev. 2021;52(4):654–68.
doi: 10.1007/s10578-020-01051-z pubmed: 32880036
Wheeler AC, Sacco P, Cabo R. Unmet clinical needs and burden in Angelman syndrome: a review of the literature. Orphanet J Rare Dis. 2017;12(1):164.
doi: 10.1186/s13023-017-0716-z pubmed: 29037196 pmcid: 5644259
Miodrag N, Peters S. Parent stress across molecular subtypes of children with Angelman syndrome. J Intellect Disabil Res. 2015;59(9):816–26.
doi: 10.1111/jir.12195 pubmed: 25833412
A Stabel. Daily Living Skills. In: Volkmar FR, editor. Encyclopedia of Autism Spectrum Disorders. New York, NY: Springer. York: New; 2013. p. 839–40.
Summers J, Szatmari P. Using discrete trial instruction to teach children with Angelman syndrome. Focus on Autism and Other Developmental Disabilities. 2009;24(4):216–26.
doi: 10.1177/1088357609334057
Radstaake M, Didden R, Peters-Scheffers N, Moore DW, Anderson A, Curfs LM. Toilet training in individuals with Angelman syndrome: a case series. Dev Neurorehabil. 2014;17(4):243–50.
doi: 10.3109/17518423.2013.783140 pubmed: 23957894
Didden R, Sikkema SP, Bosman IT, Duker PC, Curfs LM. Use of a modified Azrin-Foxx toilet training procedure with individuals with Angelman syndrome. J Appl Res Intellect Disabil. 2001;14(1):64–70.
doi: 10.1046/j.1468-3148.2001.00047.x
Treharne DA. Parental recall of children’s early development. Eur J Disord Commun. 1992;27(3):221–30.
doi: 10.3109/13682829209029422 pubmed: 1306388
Majnemer A, Rosenblatt B. Reliability of parental recall of developmental milestones. Pediatr Neurol. 1994;10(4):304–8.
doi: 10.1016/0887-8994(94)90126-0 pubmed: 8068156
Ozonoff S, Iosif AM, Young GS, Hepburn S, Thompson M, Colombi C, Cook IC, Werner E, Goldring S, Baguio F, Rogers SJ. Onset patterns in autism: correspondence between home video and parent report. Journal of the American Academy of Child & Adolescent Psychiatry. 2011 Aug 1;50(8):796–806. 41. Zubler JM, Wiggins LD, Macias MM, Whitaker TM, Shaw JS, Squires JK, Pajek JA, Wolf RB, Slaughter KS, Broughton AS, Gerndt KL, Mlodoch BJ, Lipkin PH. Evidence-Informed Milestones for Developmental Surveillance Tools. Pediatrics. 2022;149(3):e2021052138.

Auteurs

Anjali Sadhwani (A)

Department of Psychiatry and Behavioral Services, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Anjali.sadhwani@childrens.harvard.edu.
Department of Psychiatry and Behavioral Services, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. Anjali.sadhwani@childrens.harvard.edu.

Sonya Powers (S)

RTI International, Research Triangle Park, NC, USA.
Edmentum, Minneapolis, MN, USA.

Anne Wheeler (A)

RTI International, Research Triangle Park, NC, USA.

Hillary Miller (H)

Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Aetna, Hartford, CT, USA.

Sarah Nelson Potter (SN)

RTI International, Research Triangle Park, NC, USA.

Sarika U Peters (SU)

Vanderbilt University School of Medicine, Nashville, TN, USA.

Carlos A Bacino (CA)

Kleberg Genetics Clinic, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.

Steven A Skinner (SA)

Greenwood Genetic Center, Greenwood, SC, USA.

Logan K Wink (LK)

Division of Child Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.
Talkiatry Management Services, LLC, New York, USA.

Craig A Erickson (CA)

Division of Child Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.

Lynne M Bird (LM)

University of California San Diego and Rady Children's Hospital, San Diego, CA, USA.

Wen-Hann Tan (WH)

Department of Psychiatry and Behavioral Services, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH